Guangxi Wuzhou Zhongheng Group Co.,Ltd — Investor Relations & Filings
About Guangxi Wuzhou Zhongheng Group Co.,Ltd
Guangxi Wuzhou Zhongheng Group Co., Ltd. is a diversified enterprise primarily engaged in the research, development, manufacturing, and distribution of pharmaceutical products and health-oriented consumer goods. The company specializes in the modernization of Traditional Chinese Medicine (TCM), with a core focus on cardiovascular and cerebrovascular treatments. Its flagship product, Xueshuantong (Panax Notoginseng Saponins for injection), is a widely recognized treatment for vascular diseases. Beyond pharmaceuticals, the group operates in the health food sector, producing functional beverages and traditional snacks such as Guilinggao (tortoise jelly). The company integrates advanced manufacturing technologies with traditional formulations to serve domestic and international markets, emphasizing product quality, clinical efficacy, and the expansion of its healthcare ecosystem.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 广西梧州中恒集团股份有限公司关于公司董事、财务负责人辞职暨选举职工代表董事的公告 | 2026-03-31 | Chinese | |
| 广西梧州中恒集团股份有限公司关于召开2025年年度股东会的通知 | 2026-03-30 | Chinese | |
| 广西梧州中恒集团股份有限公司2025年度独立董事述职报告(李骅) | 2026-03-30 | Chinese | |
| 广西梧州中恒集团股份有限公司关于2025年度独立董事独立性自查情况的专项意见 | 2026-03-30 | Chinese | |
| 广西梧州中恒集团股份有限公司2025年度内部控制审计报告 | 2026-03-30 | Chinese | |
| 广西梧州中恒集团股份有限公司2025年度审计报告 | 2026-03-30 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 40629121 | 广西梧州中恒集团股份有限公司关于公司董事、财务负责人辞职暨选举职工代表董事的公告 | 2026-03-31 | Chinese | ||
| 40629114 | 广西梧州中恒集团股份有限公司关于召开2025年年度股东会的通知 | 2026-03-30 | Chinese | ||
| 40629108 | 广西梧州中恒集团股份有限公司2025年度独立董事述职报告(李骅) | 2026-03-30 | Chinese | ||
| 40629100 | 广西梧州中恒集团股份有限公司关于2025年度独立董事独立性自查情况的专项意见 | 2026-03-30 | Chinese | ||
| 40629088 | 广西梧州中恒集团股份有限公司2025年度内部控制审计报告 | 2026-03-30 | Chinese | ||
| 40628878 | 广西梧州中恒集团股份有限公司2025年度审计报告 | 2026-03-30 | Chinese | ||
| 40628347 | 广西梧州中恒集团股份有限公司2025年年度报告摘要 | 2026-03-30 | Chinese | ||
| 40628336 | 广西梧州中恒集团股份有限公司2025年度独立董事述职报告(龚行楚) | 2026-03-30 | Chinese | ||
| 40628325 | 广西梧州中恒集团股份有限公司关于2025年度拟不进行利润分配的公告 | 2026-03-30 | Chinese | ||
| 40628321 | 广西梧州中恒集团股份有限公司2025年度内部控制评价报告 | 2026-03-30 | Chinese | ||
| 40628312 | 广西梧州中恒集团股份有限公司对会计师事务所2025年度履职情况评估报告 | 2026-03-30 | Chinese | ||
| 40628303 | 广西梧州中恒集团股份有限公司董事会审计委员会2025年度对会计师事务所履行监督职责情况报告 | 2026-03-30 | Chinese | ||
| 40628297 | 广西梧州中恒集团股份有限公司第十届董事会第三十九次会议决议公告 | 2026-03-30 | Chinese | ||
| 40628290 | 广西梧州中恒集团股份有限公司关于2026年度综合授信额度下向金融机构申请授信用信担保的公告 | 2026-03-30 | Chinese | ||
| 40628282 | 广西梧州中恒集团股份有限公司2025年度独立董事述职报告(陈道峰) | 2026-03-30 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Guangxi Wuzhou Zhongheng Group Co.,Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56599/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56599 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56599 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56599 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56599}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Guangxi Wuzhou Zhongheng Group Co.,Ltd (id: 56599)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.